Showing results (1621-1630 of 9,596) with videos related to
Sort By:
Pageof 960
Pharmaceutical Research|April 3, 2023
Pre-clinical Formulation Development of an in situ Meglumine Salt of AZD5991: A Novel Macrocyclic Mcl-1 InhibitorWenzhan Yang, Steve Cook, Dedong WuPharmaceutical Research|April 6, 2023
Trends in Light and Temperature Sensitivity Recommendations among Licensed Biotechnology Drug ProductsJennifer J Kim, Jordan D Pritts, Mai Ngo, et al.Pharmaceutical Research|April 21, 2021
Solvent-Casted Films to Assist Polymer Selection for Amorphous Solid Dispersions During Preclinical Studies: In-vitro and In-vivo ExplorationLaura I Mosquera-Giraldo, Maria Donoso, Kevin Stefanski, et al.Pharmaceutical Research|October 12, 2012
Pharmaceutical differences between block copolymer self-assembled and cross-linked nanoassemblies as carriers for tunable drug releaseHyun Jin Lee, Younsoo BaePharmaceutical Research|July 17, 2008
The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrolSurajit Das, Hai-Shu Lin, Paul C Ho, et al.Pharmaceutical Research|September 8, 2007
Hormonal regulation of BCRP expression in human placental BeWo cellsHonggang Wang, Jashvant D Unadkat, Qingcheng MaoPharmaceutical Research|July 16, 2008
Cancer is a preventable disease that requires major lifestyle changesPreetha Anand, Ajaikumar B Kunnumakkara, Ajaikumar B Kunnumakara, et al.Pharmaceutical Research|June 20, 2008
Evidence for a new crystalline phase of racemic IbuprofenEmeline Dudognon, Florence Danède, Marc Descamps, et al.Pharmaceutical Research|June 17, 2006
Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrierGrégoire Dirson, Christine Fernandez, Patrick Hindlet, et al.Pharmaceutical Research|June 17, 2006
Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradationChun Chu, Yun Zhang, Ruben J Boado, et al.Pageof 960